Synergy Innovation (A048870) Stock Overview
Engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A048870 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Synergy Innovation Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,060.00 |
| 52 Week High | ₩4,640.00 |
| 52 Week Low | ₩1,925.00 |
| Beta | 0.098 |
| 1 Month Change | -15.57% |
| 3 Month Change | -15.23% |
| 1 Year Change | -25.90% |
| 3 Year Change | -34.19% |
| 5 Year Change | -30.64% |
| Change since IPO | -98.01% |
Recent News & Updates
Shareholders Will Be Pleased With The Quality of Synergy Innovation's (KOSDAQ:048870) Earnings
Nov 21
There May Be Reason For Hope In Synergy Innovation's (KOSDAQ:048870) Disappointing Earnings
May 22Earnings Not Telling The Story For Synergy Innovation Co., Ltd. (KOSDAQ:048870) After Shares Rise 50%
Apr 16Recent updates
Shareholders Will Be Pleased With The Quality of Synergy Innovation's (KOSDAQ:048870) Earnings
Nov 21There May Be Reason For Hope In Synergy Innovation's (KOSDAQ:048870) Disappointing Earnings
May 22Earnings Not Telling The Story For Synergy Innovation Co., Ltd. (KOSDAQ:048870) After Shares Rise 50%
Apr 16Synergy Innovation (KOSDAQ:048870) Has A Pretty Healthy Balance Sheet
Dec 17We Think You Can Look Beyond Synergy Innovation's (KOSDAQ:048870) Lackluster Earnings
Nov 20Earnings Not Telling The Story For Synergy Innovation Co., Ltd. (KOSDAQ:048870) After Shares Rise 28%
Sep 09Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Investors Can Find Comfort In Synergy Innovation's (KOSDAQ:048870) Earnings Quality
Mar 31A Look At The Intrinsic Value Of Synergy Innovation Co., Ltd. (KOSDAQ:048870)
May 03There's Been No Shortage Of Growth Recently For Synergy Innovation's (KOSDAQ:048870) Returns On Capital
Apr 07Is Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shareholder Ownership Skewed Towards Insiders?
Mar 11Investors Who Bought Synergy Innovation (KOSDAQ:048870) Shares A Year Ago Are Now Up 76%
Feb 13Is Synergy Innovation (KOSDAQ:048870) Using Too Much Debt?
Jan 17Here’s What’s Happening With Returns At Synergy Innovation (KOSDAQ:048870)
Dec 22Is Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shareholder Ownership Skewed Towards Insiders?
Nov 26Shareholder Returns
| A048870 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -3.5% | -9.0% | -15.1% |
| 1Y | -25.9% | -12.1% | 97.8% |
Return vs Industry: A048870 underperformed the KR Medical Equipment industry which returned -12.1% over the past year.
Return vs Market: A048870 underperformed the KR Market which returned 97.8% over the past year.
Price Volatility
| A048870 volatility | |
|---|---|
| A048870 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in KR Market | 15.0% |
| 10% least volatile stocks in KR Market | 4.1% |
Stable Share Price: A048870 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A048870's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 72 | Han-Ki Kim | www.synergyinno.com |
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents.
Synergy Innovation Co., Ltd. Fundamentals Summary
| A048870 fundamental statistics | |
|---|---|
| Market cap | ₩181.50b |
| Earnings (TTM) | ₩11.27b |
| Revenue (TTM) | ₩106.25b |
Is A048870 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A048870 income statement (TTM) | |
|---|---|
| Revenue | ₩106.25b |
| Cost of Revenue | ₩59.82b |
| Gross Profit | ₩46.43b |
| Other Expenses | ₩35.16b |
| Earnings | ₩11.27b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 127.87 |
| Gross Margin | 43.70% |
| Net Profit Margin | 10.60% |
| Debt/Equity Ratio | 11.5% |
How did A048870 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/10 00:55 |
| End of Day Share Price | 2026/03/10 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Synergy Innovation Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wonjae Park | Mirae Asset Securities Co., Ltd. |
| Dohan Kim | Samsung Securities Co. Ltd. |
| SeungHo Lee | Shinhan Investment Corp. |